Myriad Genetics Inc. Earnings

Myriad Genetics Inc.’s revenue jumped 0.76% since last year same period to $213.1Mn in the Q2 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 8.78% jump in its revenue since last 3-months.

Myriad Genetics Inc.’s net profit fell -800.54% since last year same period to $-330.5Mn in the Q2 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated -330400% fall in its net profits since last 3-months.

Myriad Genetics Inc.’s net profit margin fell -793.78% since last year same period to -155.09% in the Q2 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated -303724.26% fall in its net profit margins since last 3-months.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a -16% fall from last quarter’s estimates.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at -0.01.

Myriad Genetics Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Myriad Genetics Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.